Amelioration of non-alcoholic fatty liver disease by targeting G protein-coupled receptor 110: A preclinical study
Mengyao Wu, Tak-Ho Lo, Liping Li, Jia Sun, Chujun Deng, Ka-Ying Chan, Xiang Li, Steve Ting-Yuan Yeh, Jimmy Tsz Hang Lee, View ORCID ProfilePauline Po Yee Lui, Aimin Xu, View ORCID ProfileChi-Ming Wong
doi: https://doi.org/10.1101/2022.12.07.22283206
Mengyao Wu
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
Tak-Ho Lo
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
Liping Li
2Zhujiang Hospital, Southern Medical University, China
Jia Sun
2Zhujiang Hospital, Southern Medical University, China
Chujun Deng
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
Ka-Ying Chan
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
Xiang Li
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
Steve Ting-Yuan Yeh
3Ionis Pharmaceuticals, USA
Jimmy Tsz Hang Lee
4Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
5The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong SAR, China
Pauline Po Yee Lui
6Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China
Aimin Xu
4Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
5The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong SAR, China
Chi-Ming Wong
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
5The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong SAR, China
7Hong Kong Polytechnic University Shenzhen Research Institute, China

Article usage
Posted December 12, 2022.
Amelioration of non-alcoholic fatty liver disease by targeting G protein-coupled receptor 110: A preclinical study
Mengyao Wu, Tak-Ho Lo, Liping Li, Jia Sun, Chujun Deng, Ka-Ying Chan, Xiang Li, Steve Ting-Yuan Yeh, Jimmy Tsz Hang Lee, Pauline Po Yee Lui, Aimin Xu, Chi-Ming Wong
medRxiv 2022.12.07.22283206; doi: https://doi.org/10.1101/2022.12.07.22283206
Amelioration of non-alcoholic fatty liver disease by targeting G protein-coupled receptor 110: A preclinical study
Mengyao Wu, Tak-Ho Lo, Liping Li, Jia Sun, Chujun Deng, Ka-Ying Chan, Xiang Li, Steve Ting-Yuan Yeh, Jimmy Tsz Hang Lee, Pauline Po Yee Lui, Aimin Xu, Chi-Ming Wong
medRxiv 2022.12.07.22283206; doi: https://doi.org/10.1101/2022.12.07.22283206
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3086)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4834)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3057)
- Health Policy (1101)
- Hematology (410)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4606)
- Nursing (244)
- Nutrition (684)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1239)
- Primary Care Research (520)
- Public and Global Health (7189)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (221)
- Urology (189)